Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status.
Unger K, Fleischmann DF, Ruf V, Felsberg J, Piehlmaier D, Samaga D, Hess J, Suresh MP, Mittelbronn M, Lauber K, Budach W, Sabel M, Rödel C, Reifenberger G, Herms J, Tonn JC, Zitzelsberger H, Belka C, Niyazi M.
Unger K, et al. Among authors: suresh mp.
Neurooncol Adv. 2020 Oct 15;2(1):vdaa137. doi: 10.1093/noajnl/vdaa137. eCollection 2020 Jan-Dec.
Neurooncol Adv. 2020.
PMID: 33305269
Free PMC article.